Submit a Manuscript to the Journal
Cancer Biology & Therapy
For an Article Collection on
The Current State of Chemoprevention
Manuscript deadline
Article collection guest advisor(s)
Dr. Lisa Barroilhet,
University of Wisconsin
The Current State of Chemoprevention
The need to provide safe and cost-effective measures to prevent cancer is self-explanatory Chemoprevention refers to the use of natural or synthetic substances to prevent, suppress, or delay the development of cancer. The goal of chemoprevention is to reduce the risk of cancer in individuals who may be at higher risk, either due to genetic factors, lifestyle, or environmental exposures. This approach can involve dietary and lifestyle changes, targeting pre-cancerous conditions, and pharmacological agents. While there have been tremendous successes in this field (HPV vaccination for cervical cancer prevention, tamoxifen for breast cancer prevention and aspirin for colorectal cancer prevention), novel approaches are needed.
The economic burden of cancer in the U.S. is substantial, encompassing direct medical costs, indirect costs (such as lost productivity), and intangible costs (like reduced quality of life). In 2024, our country’s cancer-related medical costs are estimated to be greater than $210 billion. This figure is expected to continue to rise significantly due to increasing cancer incidence, treatment costs and our aging population. While we have made tremendous gains in the effective treatment of cancer over the past decade, with novel target therapies and immunotherapies making previously incurable disease curable, the costs and quality of life ramifications of cancer treatments cannot be overstated. Preventing cancer before patients are faced with challenging treatment decisions and enormous life disruption, not to mention the sequelae of treatment, which can be debilitating, is a critical goal.
We invite submissions that explore various aspects of cancer prevention research, including but not limited to the discovery and validation of potential prevention medications, repurposing medications for cancer prevention, translational approaches in vaccine development, biomarker development, and potential surrogate endpoints to consider in larger prevention trials. We welcome original research articles, reviews, and perspective pieces that expand the understanding of cancer prevention and contribute to the development of more chemoprevention agents.
***
| Guest Advisor Dr. Barroilhet is an Associate Professor in the department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. Dr. Barroilhet joined the University of Wisconsin Department of Obstetrics and Gynecology in 2012. She has been the recipient of the NCI Clinical Care Team Leadership Award and has led multiple clinical trials. Most recently she has been funded by the Reproductive Science Development Program and the NCI, where she has an R01 award entitled Repurposing Atovaquone for the Prevention of Ovarian Cancer. Her primary research interests focus on prevention and early detection of ovarian cancer in a high-risk population. Dr. Barroilhet has published in numerous peer-reviewed journals and has been active in presenting research at national conferences. She has been recognized with multiple awards by her peers for exemplary teaching of residents and staff as well as patient care.
*** All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is November 14, 2025 Please contact Cassie at Cassie.Houtz@taylorandfrancis.com with queries or to request a discount code for submissions to this Collection. |
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.